that he doesnât care about for priceless finds.â
âIs there something inherently wrong with doing that?â
A shrug. âItâs what he does and doesnât do next. Doesnât test âem long enough to determine whether theyâre invasives. Doesnât remunerate some poor, benighted country that heâs filched them from after he makes a ton of money off them.â Nate Bernstein smiled, but cynically. âOtherwise, thereâs nothing wrong with that.â
She said, âBut Matthew Flynn has a different slant. Heâs only interested in plants with medicinal value.â
The young man pointed an accusing finger at Louise. âThatâs not the whole story. Heâs got two games going. He also goes out and plunders the wilds for ornamentals for fun and profit, donât think he doesnât. As for the âvaluableâ medicinal plants heâs always touting, you have to ask, plants with value to whom? To Matthew Flynn first and foremost.â He shook his head. âNo, if you knew the whole story, youâd see heâs a phony. Nothing, or almost nothing, has panned outâno medical miracles or breakthroughsâdespite all the money heâs taken up front from the NSF and from pharmaceutical companies.â
âHuh,â said Louise. âThen why does he have such a great reputation in the scientific community?â
Bernstein, after his animated disclosures, seemed to have wound down. There was a long pause before he continued. âI predict heâll be passé before the yearâs over and that golden boy image will begin to fade. Pretty soon, the funding wonât be renewed.â Another dry and humorless laugh. âWithout NSF and pharmaceutical company money behind them, whoâll pay for Flynn and Wyantâs druggy little trips to the middle of nowhere?â He caught Louiseâs eye again. âThose trips cost big money, you know, the boats, the special equipment, the professional crews from Manaus . . .â
âI heard Dr. Flynn and Wyant discovered a promising new species. Something in the uncaria genus .â
Bernstein nodded. âA subspecies of Uncaria quianensis; Iâve read all about it. Maybe itâs a breakthrough, but I donât think so, despite all the hoopla in the scientific press about it. If it did become a bona fide cancer cure the way theyâve been touting it, it will be an all-out steal from those poor Peruvian Indians who live where they found the plant. But watch and see. I bet their promises come to nothing. Time will tell if Iâm right.â
Louise thought for a moment, but a moment was all she had, for Nate Bernstein had reached the front of the line. She noticed he was purchasing a pocket knife with an attractive palm tree motif. Her newly aroused shopping âselfâ decided sheâd buy one for her husband as a fitting gift from Kauai. She touched his arm. âNate, weâll give Dr. Reuter plenty of opportunity to state his positions tomorrow on endangered and invasive plants.â
Bernstein turned and threw the words over his shoulder. âI trust you on that, Mrs. Eldridge.â
Then, not caring that he was holding up a line of people, he turned all the way around and fixed Louise with his intense gaze. In a quiet voice that couldnât be overheard, he said, âI donât trust the others not to skewer the deal and dominate your whole program.â
âOh, no, theyââ she started to say, but he raised a warning hand that was as good as if heâd told her to be quiet and listen.
âLetâs look at the facts as they exist, Mrs. Eldridge. When it comes to botanists, Matthew Flynn is the young, womanizing glamour-puss with the compelling scientific spiel. And that old goat Bouting doesnât do so bad for himself . . . either with the ladies or at conning the scientific community into thinking that heâs their